NYSE : ASPN

Aspen Aerogels, Inc.

$5.235 USD

$0.18 (3.66%)

Volume
486.08K
Average Volume
1.64M
Market Capitalization
$433.86M
P/E Ratio
-3.85
Dividend Yield
0.00%
Price Target
$4.88
Year High
$9.78
Year Low
$2.30
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.88
Source Headline
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth

globenewswire.com - 2026-07-15 08:30:00

Aspen Aerogels Named a 2025 Supplier of the Year by General Motors

NORTHBOROUGH, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in aerogel-based sustainability and electrification solutions, today announced that it has been named a 2025 General Motors Supplier of the Year.

globenewswire.com - 2026-06-03 16:30:00

Aspen Aerogels Begins Staged Restart of East Providence Facility

NORTHBOROUGH, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced the successful initiation of a staged restart of its manufacturing operations at its East Providence, Rhode Island facility.

globenewswire.com - 2026-05-14 16:30:00

Aspen Aerogels Q1 Earnings Call Highlights

Aspen Aerogels NYSE: ASPN said it expects revenue to improve sequentially through 2026 despite a first-quarter sales decline, a temporary shutdown at its East Providence, Rhode Island, manufacturing facility and continued volatility in electric vehicle-related demand.

marketbeat.com - 2026-05-09 08:07:56

Aspen Aerogels, Inc. (ASPN) Q1 2026 Earnings Call Transcript

Aspen Aerogels, Inc. (ASPN) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-07 10:01:16

Aspen Aerogels (ASPN) Reports Q1 Loss, Tops Revenue Estimates

Aspen Aerogels (ASPN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.06 per share a year ago.

zacks.com - 2026-05-07 08:46:26

Aspen Aerogels, Inc. Reports First Quarter 2026 Financial Results and Recent Business Highlights

East Providence manufacturing facility expected to have a staged restart beginning in May $175.6 million quarter-end cash balance; up from $158.6 million at year-end 2025 Secured an additional subsea pipeline award to be delivered in Q3 2026

globenewswire.com - 2026-05-07 06:30:00

Aspen Aerogels, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call

NORTHBOROUGH, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced that Don Young, President & Chief Executive Officer, and Grant Thoele, Chief Financial Officer & Treasurer, expect to discuss the Company's financial results for the first quarter ended March 31, 2026, during a conference call scheduled for Thursday, May 7, 2026, at 8:30 a.m. ET. The Company also expects to release its quarterly financial results before the market opens on Thursday, May 7, 2026.

globenewswire.com - 2026-04-23 08:00:00

Aspen Aerogels Provides East Providence Facility Update

NORTHBOROUGH, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today provided an update on its manufacturing facility in East Providence, Rhode Island.

globenewswire.com - 2026-04-21 16:30:00

Get ASPN Insider Trade Alerts

ASPN Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$4.88

2 analysts

Last Year

$4.88

2 analysts

All Time

$28.78

15 analysts

ASPN Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-05-11 Barclays Maintain Underweight Underweight
2026-03-05 Barclays Maintain Underweight Underweight
2026-02-26 Roth Capital Maintain Buy Buy
2026-02-26 TD Cowen Maintain Buy Buy
2025-11-07 Barclays Maintain Underweight Underweight
2025-11-07 Canaccord Genuity Maintain Buy Buy
2025-08-11 Barclays Downgrade Equal Weight Underweight
2025-08-08 Canaccord Genuity Maintain Buy Buy
2025-05-29 Barclays Downgrade Overweight Equal Weight
2025-02-19 B. Riley Securities Maintain Buy Buy
2025-02-19 Barclays Maintain Overweight Overweight
2025-02-14 Roth MKM Maintain Buy Buy
2025-02-14 Canaccord Genuity Maintain Buy Buy
2025-02-14 Craig-Hallum Maintain Buy Buy
2025-02-13 Seaport Global Downgrade Buy Neutral
2025-01-24 Craig-Hallum Maintain Buy Buy
2025-01-16 Canaccord Genuity Maintain Buy Buy
2024-11-12 Barclays Maintain Overweight Overweight
2024-11-08 Roth MKM Maintain Buy Buy
2024-10-22 Piper Sandler Maintain Overweight Overweight
2024-10-16 HC Wainwright & Co. Maintain Buy Buy
2024-08-21 Roth MKM Maintain Buy Buy
2024-08-20 TD Cowen Maintain Buy Buy
2024-08-09 HC Wainwright & Co. Maintain Buy Buy
2024-08-08 Benchmark Maintain Buy Buy
2024-06-14 Craig-Hallum Maintain Buy Buy
2024-06-13 Seaport Global Maintain Buy Buy
2024-06-12 Roth MKM Maintain Buy Buy
2024-06-05 TD Cowen Maintain Buy Buy
2024-05-29 Piper Sandler Maintain Overweight Overweight
2024-05-14 Piper Sandler Maintain Overweight Overweight
2024-05-03 Piper Sandler Maintain Overweight Overweight
2024-05-03 Canaccord Genuity Maintain Buy Buy
2024-05-03 HC Wainwright & Co. Maintain Buy Buy
2024-05-03 Roth MKM Maintain Buy Buy
2024-05-03 B. Riley Securities Maintain Buy Buy
2024-04-30 Roth MKM Maintain Buy Buy
2024-02-14 Canaccord Genuity Maintain Buy Buy
2024-02-14 HC Wainwright & Co. Maintain Buy Buy
2024-01-16 HC Wainwright & Co. Maintain Buy Buy
2023-12-27 Canaccord Genuity Maintain Buy Buy
2023-08-04 HC Wainwright & Co. Maintain Buy Buy
2023-06-16 Canaccord Genuity Maintain Buy Buy
2023-03-20 Benchmark Upgrade Hold Buy
2023-02-22 Piper Sandler Maintain Overweight Overweight
2023-02-17 Canaccord Genuity Maintain Buy Buy
2022-12-13 B. Riley Securities Maintain Buy Buy
2022-07-07 Craig-Hallum Maintain Buy Buy
2022-07-01 EF Hutton Maintain Buy Buy
2022-05-03 Canaccord Genuity Maintain Buy Buy
2022-04-29 EF Hutton Maintain Buy Buy
2022-04-29 B. Riley Securities Maintain Buy Buy
2022-02-18 HC Wainwright & Co. Maintain Buy Buy
2022-02-18 Piper Sandler Maintain Overweight Overweight
2021-12-10 Benchmark Maintain Buy Buy
2021-09-10 Piper Sandler Maintain Overweight Overweight
2021-08-17 Oppenheimer Maintain Outperform Outperform
2021-07-30 Canaccord Genuity Maintain Buy Buy
2021-07-01 HC Wainwright & Co. Upgrade Neutral Buy
2021-07-01 Canaccord Genuity Maintain Buy Buy
2020-10-30 HC Wainwright & Co. Maintain Buy Buy
2020-09-09 Northland Capital Markets Maintain Outperform Outperform
2020-05-04 B. Riley Securities Maintain Buy Buy
2020-05-04 B. Riley FBR Maintain Buy Buy
2020-01-28 Canaccord Genuity Maintain Buy Buy
2020-01-23 B. Riley FBR Maintain Buy Buy
2020-01-23 B. Riley Maintain Buy Buy
2019-07-22 H.C. Wainwright Maintain Buy Buy
2016-11-14 Citigroup Downgrade Buy Neutral
2016-11-04 Seaport Global Downgrade Buy Neutral
2016-11-04 JP Morgan Downgrade Overweight Neutral
2016-09-20 Craig-Hallum Maintain Buy Buy
2016-08-05 JP Morgan Maintain Overweight Overweight
2016-07-07 Citigroup Maintain Buy Buy
2016-04-14 KeyBanc Maintain Overweight Overweight
2015-11-06 Canaccord Genuity Maintain Buy Buy
2015-08-12 Seaport Global Maintain Buy Buy
2015-08-10 Needham Maintain Buy Buy
2015-08-07 Canaccord Genuity Maintain Buy Buy
2015-05-29 JP Morgan Maintain Overweight Overweight
2015-03-13 Citigroup Maintain Buy Buy
2015-02-17 Baird Upgrade Neutral Outperform
2014-10-16 ISI Group Maintain Buy Buy
2014-07-08 JP Morgan Maintain Overweight Overweight
2014-07-08 Citigroup Maintain Neutral Neutral
2014-07-08 Canaccord Genuity Maintain Buy Buy
2014-07-08 Baird Maintain Neutral Neutral